By Thomas H. Maugh II (LA Times) The psychedelic drug psilocybin, the active ingredient in “magic mushrooms,” can improve mood and reduce anxiety and depression in terminal cancer patients, Los Angeles researchers reported Monday.
A single modest dose of the hallucinogen, whose reputation was severely tarnished by widespread nonmedical use in the psychedelic ’60s and ethical lapses by researchers such as Timothy Leary, can improve patients’ functioning for as long as six months, allowing them to spend their last days with more peace, researchers said.
The research was a pilot study involving only 12 patients, but it is viewed as a first step in restoring the drug to respectability.
“This is a landmark study in many ways,” said Dr. Stephen Ross, clinical director of the Center of Excellence on Addiction at New York University’s Langone Medical Center, who was not involved in the research. “This is the first time a paper like this has come out in a prestigious psychiatric journal in 40 years.”
Read the rest: ‘Magic mushrooms’ ingredient beneficial to cancer patients, report says – latimes.com.
